Hundreds contact BBC about mystery skin condition ‘hell’ – but doctors can’t agree it exists
Hundreds Reach Out to BBC About ‘Hell’ Skin Condition, Yet Medical Consensus Fails
Two weeks ago, an article on BBC News explored a troubling skin issue that has sparked widespread discussion online, known as topical steroid withdrawal (TSW). While some view it as an extreme form of eczema, others argue it is a distinct condition. Despite its growing attention, the medical community remains divided on its definition and treatment. The piece resonated deeply, drawing millions of readers and prompting 240 responses from individuals sharing their experiences.
Now, the author has delved further into the matter, speaking with patients and healthcare professionals to uncover why TSW continues to puzzle experts. Bethany Norman, a 36-year-old mother, recalls clutching her infant son while wrapped in bandages. Her child had eczema, yet she refused steroid creams, fearing they would harm him as they had her. “See what this medication did to me? Why would I risk it on my own son?” she remembers shouting. For Bethany, the creams had left her with raw skin, relentless itching, and unceasing flaking—feelings she likened to being trapped in her own body.
Meanwhile, Dr. Pippa Bowes, an urgent care specialist in Southampton, highlights the communication gap. “Breakdowns can occur when patients feel their concerns are dismissed,” she notes. “Some medical staff struggle to grasp what’s happening, leaving patients without clear answers.” This tension is evident in Jenna Crosbie’s experience. A trainee GP in north Wales, she initially couldn’t fathom why a patient would reject steroid creams. “Eczema treatments were always prescribed first,” she explains, until her own skin began reacting differently after prolonged use.
TSW gained official recognition in 2021 by the MHRA, the UK’s medicines regulator, as a possible reaction to long-term steroid cream use. However, it is not yet classified as a formal diagnosis. Patients report symptoms that deviate from typical eczema, such as persistent rashes and intense itching, which often persist even after stopping the medication. This has led to frustration, with some feeling their conditions are misunderstood or dismissed.
Dr. Dean Eggit, a GP in Doncaster, suggests that misdiagnosis might be a factor. “Steroid creams are essential, but they can be overused,” he says. “Doctors sometimes prescribe them without fully investigating the root cause. The initial eczema rash can resemble TSW, making it hard to distinguish.” This uncertainty puts patients in a difficult position, questioning whether the very treatments they rely on could be exacerbating their issues.
Guidelines from the National Institute for Health and Clinical Excellence (NICE) recommend a gradual approach to eczema care, starting with emollients before introducing steroids. However, these steps are not always followed. Dr. Adrian Hayter, from the Royal College of GPs, emphasizes the need for regular check-ins: “If a patient is on a repeated steroid prescription, we must ensure they’re using it appropriately and monitoring for adverse effects.”
The Path to Understanding
As more cases emerge, the medical field faces growing pressure to reconcile patient experiences with clinical evidence. For some, like Jenna Crosbie, this journey has transformed their perspective. “I now see what that A&E patient was dealing with,” she says. “It’s a painful process, but it’s also a lesson in listening to the body’s signals.”
“I wouldn’t wish this on my worst enemy,” Jenna adds, reflecting on the struggle of living with TSW.
With limited research and no definitive diagnosis, the debate over TSW continues. Patients and doctors alike seek clarity, hoping to find a way forward in managing a condition that feels both familiar and alien.
